drugset / Trial / NCT01068951
Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells
RandomizedParallel-groupOpen-labelPrevention
Summary
The main hypothesis of the investigators study is that the development of autoimmune diabetes may be halted att diagnosis by the immune modulatory properties of mesenchymal stem cells.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | mesenchymal stem cells | Cell therapy | 2e+06 cells/kg | Intravenous |